Pharmocann Global (XTAE:PMCN-M) Total Stockholders Equity : ₪0.76 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global Total Stockholders Equity?

Pharmocann Global's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₪0.76 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pharmocann Global's Book Value per Share for the quarter that ended in Dec. 2023 was ₪0.34. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pharmocann Global's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.51.

Pharmocann Global Total Stockholders Equity Historical Data

The historical data trend for Pharmocann Global's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmocann Global Total Stockholders Equity Chart

Pharmocann Global Annual Data

Trend

Dec09

Dec10

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

31.63

41.10

25.42

7.76

0.76

Pharmocann Global Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															18.38	17.07	7.76	3.37	0.76

Pharmocann Global (XTAE:PMCN-M) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pharmocann Global's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.761	-	0)	/	2.22796
	=	0.34

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pharmocann Global's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.197	+	0.194)	/	0.761
	=	0.51

Pharmocann Global Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmocann Global (XTAE:PMCN-M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201

Website

https://www.pharmocann.co.il

Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global (XTAE:PMCN-M) Headlines

No Headlines